Squamous Cell Carcinoma Metastatic to the Thyroid Gland Diagnosed by Fine-Needle Aspiration Cytology: A Case Report.
Fine-needle aspiration cytology of the thyroid gland has been widely used for the initial diagnosis of suspected malignant thyroid nodules and definitive preoperative diagnosis of recurrent and metast
APA
Wei X, Chen Z, et al. (2025). Squamous Cell Carcinoma Metastatic to the Thyroid Gland Diagnosed by Fine-Needle Aspiration Cytology: A Case Report.. Cureus, 17(4), e82665. https://doi.org/10.7759/cureus.82665
MLA
Wei X, et al.. "Squamous Cell Carcinoma Metastatic to the Thyroid Gland Diagnosed by Fine-Needle Aspiration Cytology: A Case Report.." Cureus, vol. 17, no. 4, 2025, pp. e82665.
PMID
40400806
Abstract
Fine-needle aspiration cytology of the thyroid gland has been widely used for the initial diagnosis of suspected malignant thyroid nodules and definitive preoperative diagnosis of recurrent and metastatic thyroid cancer. Metastases to the thyroid most commonly arise from tumors in the lungs, kidneys, breasts, and skin. Metastatic squamous cell carcinoma can also be observed in the thyroid, but it is relatively rare. Here, we report a case of esophageal squamous cell carcinoma metastatic to the thyroid that was diagnosed using fine-needle aspiration cytology, relying on cytomorphological characteristics, immunohistochemical features, and other clinical clues.
같은 제1저자의 인용 많은 논문 (5)
- Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study.
- ASO Author Reflections: Balancing Robotic Technology, Incision Strategy, and Patient Experience in Lung Cancer Surgery.
- Long-Term Patient-Reported Outcomes after Multiport Robot-Assisted Surgery versus Video-Assisted Surgery for Lung Cancer: An Observational Cohort Study.
- ASO Visual Abstract: Long-Term Patient-Reported Outcomes After Multiport Robot-Assisted Surgery Versus Video-Assisted Surgery for Lung Cancer: An Observational Cohort Study.
- LDHA-driven lactate metabolism promotes MDSC activation and immunosuppressive microenvironment in prostate cancer.